Testing effectiveness (Phase 2)Study completedNCT01283581
What this trial is testing
Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections
Who this might be right for
Skin and Subcutaneous Tissue Bacterial Infections
Melinta Therapeutics, Inc. 256